# China Survey of Peptic Ulcer Bleeding

> **NCT01241266** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1044 (actual)

## Conditions studied

- Peptic Ulcer Hemorrhage

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01241266
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 1044 (ACTUAL)
- **Last updated:** 2011-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01241266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01241266, "China Survey of Peptic Ulcer Bleeding". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01241266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
